For example, androgen receptor and prostate-specific antigen (PSA)/kallikrein 3(KLK3) expression can significantly vary between different regions within the same prostate carcinoma (Magi-Galluzzi et al, 1997; Shah et al, 2015). This evidence concerns the gene KLK3 and prostate carcinoma.